Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICASSO AD: BPN14770 in Early Alzheimer's Disease
NCT03817684Phase 2Completed
- Sponsor
- Tetra Therapeutics
- Start
- Apr 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zatolmilast in Alzheimer's disease (AD), sponsored by Tetra Therapeutics. Started Apr 2019; status: completed.
02
Drugs
zatolmilast
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03817684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03817684.